Arm A (n = 66) | Arm B (n = 65) | |
---|---|---|
Age (years) | ||
Median (range) | 54 (33–78) | 57 (33–72) |
ECOG PS | ||
Unknown | 1 (2%) | |
0–1 | 65 (99%) | 65 (100%) |
N° CT regimens | ||
1st line | 47 (71%) | 46 (71%) |
2nd-3rd line | 19 (29%) | 19 (29%) |
ER status | ||
Positive | 43 (65%) | 38 (58%) |
Negative | 23 (35%) | 27 (42%) |
Adjuvant Anthracyclines | ||
No | 39 (59%) | 44 (68%) |
Yes | 27 (41%) | 21 (32%) |
Endocrine therapy | ||
No | 14 (21%) | 16 (24%) |
Adjuvant | 19 (29%) | 24 (37%) |
Palliative | 8 (12%) | 8 (12%) |
Disease sites | ||
Bone only | 6 (9%) | 10 (15%) |
Visceral only | 20 (30%) | 31 (48%) |
Visceral + bone | 24 (36%) | 12 (18%) |
Advanced disease at diagnosis (pM1) | 21 (32%) | 24 (37%) |